India-UK free trade deal gets Cabinet nod: Pact to be signed in London during PM Modi’s visit; aims to double trade to $120 bn

The Union Cabinet has approved the long-pending free trade agreement (FTA) between India and the United Kingdom, which is scheduled to be signed in London on July 24 during Prime Minister Narendra Modi’s visit, PTI reported citing official sources.The pact, formally called a Comprehensive Economic and Trade Agreement, was finalised on May 6 after multiple…

Read More

Blinkit boom works wonders! Deepinder Goyal richer by Rs 2,000 crore in just two days; Eternal shares see big rally

Blinkit’s blistering growth has delivered a massive windfall for Eternal CEO Deepinder Goyal, whose net worth jumped by Rs 2,000 crore in just two trading sessions, as Eternal’s stock soared over 21% and hit a fresh all-time high of Rs 311.60 on the NSE.Goyal, the 42-year-old self-made billionaire and co-founder of Eternal, now holds an…

Read More

India submits TEPA ratification document to EFTA bloc: Trade pact set to begin October 1, $100 bn investment pledged

India on Tuesday submitted the ratification document of the Trade and Economic Partnership Agreement (TEPA) with the European Free Trade Association (EFTA) to Norway, the designated depository for the pact, officials said.“India deposited the Instrument of Ratification of the TEPA between India and EFTA today at the Ministry of Foreign Affairs of Norway, which is…

Read More

US market today: Wall Street steady near record highs as GM warns of tariff pain, homebuilders rally on strong Q2

US stock markets hovered near record highs on Tuesday as investors weighed mixed earnings and trade policy signals, with General Motors flagging a $4–5 billion tariff hit for 2025, while homebuilders surged on better-than-expected second-quarter profits.The S&P 500 was little changed after reaching a fresh record on Monday. The Dow Jones Industrial Average rose 27…

Read More

Trump tariff pressure: AstraZeneca to move production to US, announces $50 billion manufacturing push

British pharmaceutical giant AstraZeneca on Tuesday announced plans to invest $50 billion in the United States, including the construction of a multi-billion-dollar manufacturing facility in Virginia—its largest-ever single manufacturing investment—amid rising pressure from the Trump administration’s tariff push.The company said it expects 50% of its total revenue to come from the US by 2030, underlining…

Read More